2C-F
Chemical compound
- BR: Class F2 (Prohibited psychotropics)
- CA: Schedule III
- UK: Class A
- 2-(4-Fluoro-2,5-dimethoxyphenyl)-1-aminoethane
- 207740-15-6 N
- 44719499
- 21106223 Y
- O01SQJ93TV
- DTXSID70660357
- Interactive image
- Fc1cc(OC)c(cc1OC)CCN
InChI
- InChI=1S/C10H14FNO2/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12/h5-6H,3-4,12H2,1-2H3 Y
- Key:QAVFEDRVOUKIPM-UHFFFAOYSA-N Y
2C-F (4-fluoro-2,5-dimethoxyphenethylamine) is a lesser-known psychedelic drug of the 2C family. It was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 250 mg.[1] 2C-F may be found as a brownish freebase oil, or as a white crystalline hydrochloride salt.
Pharmacology
Very little data exists about the pharmacological properties, metabolism, and toxicity of 2C-F[where?].
Effect
At a dose of 250 milligrams, 2C-F produces modest closed-eye visuals accompanied by lethargy.[1]
Legality
Canada
As of October 31, 2016, 2C-F is a controlled substance (Schedule III) in Canada.[2]
References
- ^ a b Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. 2C-F Entry in PiHKAL
- ^ "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". Controlled Drugs and Substances Act. 150 (9). Government of Canada. 4 May 2016.
- v
- t
- e
2C family of psychedelics
- 2C-B
- 2C-B-AN
- 2C-Bn
- 2C-Bu
- 2C-C
- 2C-CN
- 2C-CP
- 2C-D
- 2C-E
- 2C-EF
- 2C-F
- 2C-G
- 2C-G-1
- 2C-G-2
- 2C-G-3
- 2C-G-4
- 2C-G-5
- 2C-G-6
- 2C-G-N
- 2C-H
- 2C-I
- 2C-iP
- 2C-N
- 2C-NH2
- 2C-O
- 2C-O-4
- 2C-P
- 2C-Ph
- 2C-SE
- 2C-T
- 2C-T-2
- 2C-T-3
- 2C-T-4
- 2C-T-5
- 2C-T-6
- 2C-T-7
- 2C-T-8
- 2C-T-9
- 2C-T-10
- 2C-T-11
- 2C-T-12
- 2C-T-13
- 2C-T-14
- 2C-T-15
- 2C-T-16
- 2C-T-17
- 2C-T-18
- 2C-T-19
- 2C-T-20
- 2C-T-21
- 2C-T-22
- 2C-T-22.5
- 2C-T-23
- 2C-T-24
- 2C-T-25
- 2C-T-27
- 2C-T-28
- 2C-T-30
- 2C-T-31
- 2C-T-32
- 2C-T-33
- 2C-TFE
- 2C-TFM
- 2C-YN
- 2C-V